Evolution of the Average Target: Illumina, Inc.

Evolution of the Target Price: Illumina, Inc.

Changes in Analyst Recommendations: Illumina, Inc.

2170468a2cb2abec461.kmxjQEAuytpMWzBxJwo19sD31RuL-VapmdiSNMh1JTg.wANaBTRCv4h_AgdJQG5jpq6CsFXOrQ_u8qr-f7wTS2yhXzYREGis6XUMCA~0fcf4fe66b7cc21f8f70db001860a853
06:19am Analyst recommendations: Datadog, PepsiCo, Roblox, Coinbase, Nike… Zonebourse
05:55am Piper Sandler Adjusts Price Target on Illumina to $305 From $225, Keeps Overweight Rating MT
09-09 UBS Upgrades Illumina to Buy From Neutral, Adjusts Price Target to $260 From $135 MT
08-11 Illumina Building Clinical Momentum Amid Fading Competition, RBC Capital Markets Says MT
07-31 RBC Raises Price Target on Illumina to $230 From $170, Keeps Outperform Rating MT
07-13 Analyst recommendations: Biogen, Deckers Outdoor, Fortinet, Marathon Petroleum, UnitedHealth… Zonebourse
07-06 Analyst recommendations: Chubb, Delta Air Lines, Pfizer, AMD, Dow… Zonebourse
06-10 JPMorgan Upgrades Illumina to Overweight From Neutral, Price Target is $185 MT
05-15 Illumina's Mid-Teens Clinical Growth Appears Sustainable Over Next 1 to 2 Years, RBC Says MT
05-14 Daiwa Securities Upgrades Illumina to Outperform From Neutral, Adjusts Price Target to $155 From $128 MT
05-14 Analyst recommendations: Doximity, Reddit, Cisco, Whirlpool, Caterpillar… Zonebourse
02-06 UBS Adjusts Illumina Price Target to $135 From $120, Maintains Neutral Rating MT
12-03 Analyst recommendations: Applovin, Garmin, Lyft, Uber, Netflix… Zonebourse
25-10-31 'Hopeful' We'll Find Long-term Solution On China: Illumina CEO MT
25-10-31 UBS Adjusts Illumina Price Target to $120 From $110, Maintains Neutral Rating MT
25-09-03 RBC Trims Price Target on Illumina to $124 From $126, Keeps Outperform Rating MT
25-08-12 Daiwa Securities Downgrades Illumina to Neutral From Outperform, Adjusts Price Target to $94 From $124 MT
25-08-12 Analyst recommendations: Chipotle, Starbucks, Block, Doordash, Ebay… Zonebourse
25-08-01 BofA Adjusts Price Target on Illumina to $75 From $70, Maintains Underperform Rating MT
25-08-01 UBS Adjusts Illumina Price Target to $110 From $98, Maintains Neutral Rating MT
25-08-01 RBC Raises Price Target on Illumina to $126 From $118, Keeps Outperform Rating MT
25-07-11 Scotiabank Downgrades Illumina to Sector Perform From Sector Outperform, Reduces Price Target to $125 From $164 MT
25-07-09 Illumina Shares Fall After Citigroup Downgrade MT
25-07-09 Citigroup Downgrades Illumina to Sell From Neutral, Adjusts Price Target to $80 From $85 MT
25-07-09 Analyst recommendations: Illumina, Freeport-McMoran, XPO, T-Mobile US… Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
-24.94%
-3.24%
+2.82%
+17.56%
+38.89%
+17%
+1.53%
+20.46%
+2.6%
+12.71%
Average +8.54%
Weighted average by Cap. +6.88%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
270.00USD
Average target price
202.65USD
Spread / Average Target
-24.94%
High Price Target
260.00USD
Spread / Highest target
-3.70%
Low Price Target
113.00USD
Spread / Lowest Target
-58.15%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
A
  1. Stock Market
  2. Stocks
  3. ILMN Stock
  4. Consensus Illumina, Inc.